摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N5-2,4-(dichloro)phenyl biguanide hydrochloride | 6634-65-7

中文名称
——
中文别名
——
英文名称
N5-2,4-(dichloro)phenyl biguanide hydrochloride
英文别名
1-(2,4-Dichlorophenyl)biguanide hydrochloride;1-(diaminomethylidene)-2-(2,4-dichlorophenyl)guanidine;hydrochloride
N5-2,4-(dichloro)phenyl biguanide hydrochloride化学式
CAS
6634-65-7
化学式
C8H9Cl2N5*ClH
mdl
——
分子量
282.56
InChiKey
OSGGBIXVZCEAHI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    259.5-263.5 °C(lit.)

计算性质

  • 辛醇/水分配系数(LogP):
    -3.7
  • 重原子数:
    16
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    104
  • 氢给体数:
    4
  • 氢受体数:
    2

SDS

SDS:4143ed4924dd39c733f0fc018924caac
查看

反应信息

  • 作为反应物:
    描述:
    N5-2,4-(dichloro)phenyl biguanide hydrochloride盐酸 作用下, 生成 1-amidino-3-(2,4-dichlorophenyl)urea
    参考文献:
    名称:
    Douglas; Diamond; Studt, Arzneimittel-Forschung/Drug Research, 1978, vol. 28, # 8 A, p. 1435 - 1441
    摘要:
    DOI:
  • 作为产物:
    描述:
    2,4-二氯苯胺二聚氰胺盐酸 作用下, 以 正丁醇 为溶剂, 反应 2.0h, 以54%的产率得到N5-2,4-(dichloro)phenyl biguanide hydrochloride
    参考文献:
    名称:
    BIGUANIDE COMPOUNDS AND USE THEREOF
    摘要:
    本发明涉及双胍类化合物及其使用,更具体地涉及表现出对抑制癌细胞增殖、抑制癌转移和复发具有优异效果的双胍衍生物,以及制备该化合物的方法、含有该化合物作为活性成分的药物组合物,以及包括向需要的受试者施用所述组合物的有效量的步骤的癌症预防或治疗方法。
    公开号:
    US20150126518A1
点击查看最新优质反应信息

文献信息

  • 바이구아나이드 화합물 및 이의 용도
    申请人:IMMUNOMET THERAPEUTICS INC. 이뮤노메트테라퓨틱스 인코포레이티드(520150627264)
    公开号:KR20210014090A
    公开(公告)日:2021-02-08
    본 발명은 바이구아나이드 화합물 및 이의 용도에 관한 것으로서, 더욱 자세하게는 암세포 증식 억제, 암 전이와 암 재발을 억제에 우수한 효과를 나타내는 바이구아나이드 유도체, 이의 제조 방법 및 이를 유효 성분으로 함유하는 약학 조성물에 관한 것이다.
    This is the translation of the text you provided: This invention relates to biguanide compounds and their uses, more specifically to biguanide derivatives that exhibit excellent effects in inhibiting cancer cell proliferation, cancer metastasis, and cancer recurrence, as well as to a method for producing them and pharmaceutical compositions containing them as active ingredients.
  • SEMI-PERMANENT HAIR STRAIGHTENING COMPOSITION AND METHOD
    申请人:Lubrizol Advanced Materials, Inc.
    公开号:EP3065831A1
    公开(公告)日:2016-09-14
  • Semi-Permanent Hair Straightening Composition And Method
    申请人:LUBRIZOL ADVANCED MATERIALS, INC.
    公开号:US20160296449A1
    公开(公告)日:2016-10-13
    A composition and a process for straightening hair are disclosed. The process includes coating keratin fibers with a composition comprising a thermally-activated agent and a guanidine moiety containing adjuvant compound and contacting the coated keratin fibers with a heating device at a temperature of at least 185 C for sufficient time to modify the keratin fibers.
  • [EN] SEMI-PERMANENT HAIR STRAIGHTENING COMPOSITION AND METHOD<br/>[FR] COMPOSITION ET PROCÉDÉ DE DÉFRISAGE SEMI-PERMANENT DES CHEVEUX
    申请人:LUBRIZOL ADVANCED MAT INC
    公开号:WO2015069823A1
    公开(公告)日:2015-05-14
    A composition and a process for straightening hair are disclosed. The process includes coating keratin fibers with a composition comprising a thermally-activated agent and a guanidine moiety containing adjuvant compound and contacting the coated keratin fibers with a heating device at a temperature of at least 185C for sufficient time to modify the keratin fibers.
  • BIGUANIDE COMPOUNDS AND USE THEREOF
    申请人:HANALL BIOPHARMA CO., LTD.
    公开号:US20150126518A1
    公开(公告)日:2015-05-07
    The present invention relates to biguanide compounds and use thereof, more particularly, to biguanide derivatives exhibiting excellent effects for inhibition of cancer cell proliferation and inhibition of cancer metastasis and recurrence, a method for preparing the same, a pharmaceutical composition containing the same as an active ingredient, and a method of prevention or treatment of cancer comprising the step of administering an effective amount of the composition to a subject in need thereof.
    本发明涉及双胍类化合物及其使用,更具体地涉及表现出对抑制癌细胞增殖、抑制癌转移和复发具有优异效果的双胍衍生物,以及制备该化合物的方法、含有该化合物作为活性成分的药物组合物,以及包括向需要的受试者施用所述组合物的有效量的步骤的癌症预防或治疗方法。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐